In this review, we will discuss the pathogenesis of IL-22 and potential therapy targets in connective tissue diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjogren’s syndrome (SS), dermatomyositis, and systematic sclerosis (SSc). Here, IL22 is linked to Sjogren syndrome.